Lung Cancer Stocks List

Lung Cancer Stocks Recent News

Date Stock Title
May 13 VCYT Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade
May 13 OCX Oncocyte to Announce First Quarter 2024 Financial Results
May 10 EFTR eFFECTOR Therapeutics GAAP EPS of -$2.16 beats by $0.01
May 9 EFTR eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9 VCYT Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
May 8 VCYT Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
May 8 AVBP ArriVent BioPharma reports Q1 results
May 8 VCYT Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
May 8 VCYT Q1 2024 Veracyte Inc Earnings Call
May 8 VCYT Veracyte Inc (VCYT) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Revenue ...
May 8 VCYT Veracyte, Inc. (VCYT) Q1 2024 Earnings Call Transcript
May 7 VCYT Veracyte Inc (VCYT) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strong Test Performance
May 7 VCYT Veracyte, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 7 VCYT Veracyte GAAP EPS of -$0.02 beats by $0.13, revenue of $96.84M beats by $3.48M
May 7 VCYT Veracyte Announces First Quarter 2024 Financial Results
May 7 TCON TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 7 OCX PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
May 7 ICCM Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally
May 6 VCYT Veracyte Q1 2024 Earnings Preview
Lung Cancer

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.The vast majority (85%) of cases of lung cancer are due to long-term tobacco smoking. About 10–15% of cases occur in people who have never smoked. These cases are often caused by a combination of genetic factors and exposure to radon gas, asbestos, second-hand smoke, or other forms of air pollution. Lung cancer may be seen on chest radiographs and computed tomography (CT) scans. The diagnosis is confirmed by biopsy which is usually performed by bronchoscopy or CT-guidance.Avoidance of risk factors, including smoking and air pollution, is the primary method of prevention. Treatment and long-term outcomes depend on the type of cancer, the stage (degree of spread), and the person's overall health. Most cases are not curable. Common treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery, whereas SCLC usually responds better to chemotherapy and radiotherapy.Worldwide in 2012, lung cancer occurred in 1.8 million people and resulted in 1.6 million deaths. This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.

Browse All Tags